Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.

[Q]: The committee sent letters to Juul Labs Inc, 35% owned by Marlboro maker Altria Group Inc, Fontem Ventures, Japan Tobacco Inc, and Reynolds American Inc, a unit of British American Tobacco Plc. The letter to Juul asked if the company has conducted or financed studies on the health implications of using its products and the effectiveness of Juul in helping users quit smoking. It asked if Juul has sent information to the Food and Drug Administration. Kaelan Hollon, a spokeswoman for Reynolds American, said the company is reviewing the letter and believes "minors should never use tobacco products, including vapor products." Japan Tobacco said in a statement it welcomes any opportunity to "set out the responsible approaches" it takes in its marketing. Juul and Fontem Ventures did not respond to requests for comment. The probe comes amid growing scrutiny of the e-cigarette industry by lawmakers. A separate House panel in July released internal Juul emails that committee staff described as attempts to "enter schools and convey its messaging directly to teenage children." James Monsees, Juul's co-founder and chief product officer, told the panel the company's target audience is adult cigarette smokers. Representative Frank Pallone, the Democratic chair of the committee, cited vaping-related lung illnesses recently reported by the Centers for Disease Control and Prevention. He requested answers and documents by Sept. 20. The CDC said on Wednesday it is investigating 153 possible cases of severe lung illness associated with e-cigarette use in 16 states. No deaths have been reported, they said.
[A]: E-cigarette firms probed over health concerns by U.S. House panel.

[Q]: The health department said at least 16 patients admitted to the 210-bed Mount Carmel Grove City hospital after its opening April 28 have been diagnosed with Legionnaires'. The disease is a severe form of pneumonia that's caused by inhaling tiny water droplets containing the legionella bacteria. One of the patients, a 75-year-old woman, died. Hospital president Sean McKibben said in a statement Thursday that the disease outbreak happened because of inadequate disinfection of the hot water system prior to the hospital's opening. He said a permanent supplemental disinfection system with constant monitoring and controls has been installed. ___ Information from: The Columbus Dispatch, http://www.dispatch.com
[A]: Outbreak of Legionnaire's blamed on hot water system.

[Q]: The letter, sent by J&J's Tibotec Therapeutics unit to doctors this month, cited cases of drug-induced hepatitis as well as liver injury and death. "We are issuing a new warning on our labeling," Tibotec Therapeutics spokeswoman Pam Van Houten told Reuters. The company said in its letter that the problems have not been linked directly to Prezista, a once-daily protease inhibitor that was given in combination with the drug ritonavir. Ritonavir is sold by Abbott Laboratories under the name Norvir. Fifteen cases of liver problems were reported during clinical trials, Van Houten said. She added the company did not provide information on post-marketing cases reported after the drug's U.S. approval in 2006. Most of the cases occurred in patients with advanced HIV, who were taking multiple medications, as well as those who were also infected with hepatitis B or C, the letter said. The letter and Van Houten did not say how many liver-related deaths occurred. The FDA warning was released on its Web site here
[A]:
J&J, FDA warn of liver risk with HIV drug patients.